English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90120/105278 (86%)
Visitors : 9216795      Online Users : 540
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/8269


    Title: Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice
    Authors: Yiang, GT (Yiang, Giou-Teng);Harn, HJ (Harn, Horng-Jyh);Yu, YL (Yu, Yung-Luen);Hu, SC (Hu, Sheng-Chuan);Hung, YT (Hung, Yu-Ting);Hsieh, CJ (Hsieh, Chia-Jung);Lin, SZ (Lin, Shinn-Zong);Wei, CW (Wei, Chyou-Wei)
    Contributors: Department of Biotechnology
    Keywords: RECOMBINANT ADENOASSOCIATED VIRUS;DIRECTED GENE-THERAPY;CANCER A549 CELLS;IN-VIVO;EFFICIENT TRANSDUCTION;TRANSGENE EXPRESSION;IMMUNOGENE THERAPY;IMMUNE-RESPONSE;DENDRITIC CELLS;PROTEIN-KINASE
    Date: 2009-05
    Issue Date: 2010-03-26 10:29:28 (UTC+8)
    Publisher: Asia University
    Abstract: Human interleukin-15 (hIL15) has anti-tumor activities, but it is not convenient for tumor treatment because of its short half-life. A gene therapy for mouse lung cancer using an adenovirus vector expressing IL15 has been reported. However, adenovirus vector-mediated gene therapy can provoke cellular toxicity and inflammatory reactions. The recombinant adenovirus-associated vector 2 (rAAV2) is safer due to minimal cellular toxicity and immune response. In order to demonstrate that gene therapy can be used safely and successfully for human cancer treatment, the rAAV2 expressing hIL15 gene (rAAV2-hIL15) is applied for human cervical cancer, HeLa cell, in this study. This study successfully demonstrates that rAAV2-hIL15 can express IL15 with bioactivities in vitro and in vivo. In conclusion, our studies show that human cervical cancers are inhibited on animal model with rAAV2-hIL15 treatment and provide a safer and important reference for human cancer gene therapy.
    Relation: JOURNAL OF BIOMEDICAL SCIENCE 16: Art. No. 47
    Appears in Collections:[生物科技學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML213View/Open
    164.doc36KbMicrosoft Word237View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback